GlassScriptPhysician profile
Leslie C Cohan
NPI 1457316564
$2,372.95
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,602 · 2020: $304 · 2021: $81.67 · 2022: $55.82 · 2023: $255 · 2024: $74.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $646.17 | 2019 | |
| Abbvie INC. | $497.66 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Lupin INC. | $420.35 | 2019-2020 | |
| Hologic Sales and Service, LLC | $118.84 | 2019-2020 | |
| Pfizer INC. | $85.45 | 2019-2022 | |
| Ascend Therapeutics US, LLC | $84.35 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $73.11 | 2023-2024 | |
| Therapeuticsmd, INC. | $64.52 | 2019-2020 | |
| Millicent US INC | $60.43 | 2019-2023 | Femring, Intrarosa |
| Mylan Pharmaceuticals INC. | $53.03 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.34 | 2019 | |
| Astellas Pharma US INC | $43.87 | 2023 | Myrbetriq, Veozah |
| Duchesnay USA Incorporated | $32.41 | 2019 | |
| Avion Pharmaceuticals | $29.96 | 2019-2020 | |
| Dexcom, INC. | $22.35 | 2023 | Dexcom G6 Transmitter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.32 | 2023 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $19.00 | 2021 | |
| Allergan, INC. | $15.73 | 2019 | |
| Exact Sciences Corporation | $13.65 | 2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $13.30 | 2023 | Quviviq |
| Vertical Pharmaceuticals, LLC | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Cohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.